Latest news with #MN
The Star
14-05-2025
- Business
- The Star
MN Holdings wins RM37.9mil waste-to-energy project
KUALA LUMPUR: MN Holdings Bhd 's wholly owned subsidiary, Mutu Nusantara Sdn Bhd, has secured a RM37.9mil contract from a customer providing civil engineering and electrical works. The infrastructure utilities construction and engineering solutions specialist said that the company was unable to disclose the customer's identity due to a non-disclosure agreement. In a filing with Bursa Malaysia, MN said that the contract covers the design, engineering, procurement, construction, installation, testing, and commissioning (EPCC) of the waste-to-energy interconnection facility's transmission lines located in the central region of Peninsular Malaysia. The contract will take effect from May 14, 2025, and is expected to be completed by March 31, 2027. MN expects the contract to contribute positively to its future earnings and net assets per share upon commencement of the project.
Yahoo
28-03-2025
- Business
- Yahoo
Climb Bio Fueled Up with Cash, Poised for More Milestones in '25
By Exec Edge Research Climb Bio, Inc. (Nasdaq: CLYM) reported full-year results, highlighting a healthy cash cushion and several milestones for investors to watch closely during the remainder of 2025. As we highlighted in our 66-page initiation report last week (), CLYM's lead asset is Budoprutug, an anti-CD19 monoclonal antibody engineered to target diseases such as membranous nephropathy (MN), systemic lupus erythematosus and lupus nephritis (SLE/LN), and immune thrombocytopenia (ITP). The company now has regulatory clearance from the FDA for clinical trials in all three of those indications and continues to strengthen the budoprutug IP. It has begun initiating clinical trials and expects to dose patients later this year. Importantly, CLYM has cash on its balance sheet totaling $212.5 million, up from $106.8 million as of the end of 2023. Per the management, these funds are expected to be sufficient to fund the company's planned operations through 2027. Please click the link below to read the detailed quarterly update report. Rayk@ Sign in to access your portfolio
